Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MXCT NYSEAMERICAN:PTN NASDAQ:RENX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMXCTMaxCyte$0.84-3.2%$0.79$0.64▼$2.47$93.36M1.37608,364 shs358,397 shsPTNPalatin Technologies$19.47+3.0%$20.67$4.11▼$31.00$33.49M0.6315,759 shs2,482 shsRENXSafe and Green Development$2.03-7.7%$2.53$1.42▼$47.20$5.52M4.61564,698 shs113,581 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMXCTMaxCyte+2.93%-0.97%+22.75%+7.86%-68.19%PTNPalatin Technologies-0.53%-6.48%-0.53%+20.23%+1,889,999,900.00%RENXSafe and Green Development+6.80%-22.81%-17.91%-22.04%-86.71%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMXCTMaxCyte$0.84-3.2%$0.79$0.64▼$2.47$93.36M1.37608,364 shs358,397 shsPTNPalatin Technologies$19.47+3.0%$20.67$4.11▼$31.00$33.49M0.6315,759 shs2,482 shsRENXSafe and Green Development$2.03-7.7%$2.53$1.42▼$47.20$5.52M4.61564,698 shs113,581 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMXCTMaxCyte+2.93%-0.97%+22.75%+7.86%-68.19%PTNPalatin Technologies-0.53%-6.48%-0.53%+20.23%+1,889,999,900.00%RENXSafe and Green Development+6.80%-22.81%-17.91%-22.04%-86.71%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMXCTMaxCyte 2.20Hold$5.50552.20% UpsidePTNPalatin Technologies 3.00Buy$55.00182.49% UpsideRENXSafe and Green Development 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest PTN, YGEN, MXCT, and RENX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2026MXCTMaxCyte Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026RENXSafe and Green Development Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/25/2026MXCTMaxCyte Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $5.00(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMXCTMaxCyte$33.03M2.73N/AN/A$1.61 per share0.52PTNPalatin Technologies$4.49M7.68N/AN/A($4.94) per share-3.94RENXSafe and Green Development$8.22M0.62N/AN/A$9.89 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMXCTMaxCyte-$44.63M-$0.43N/AN/AN/A-135.14%-22.15%-18.98%5/12/2026 (Estimated)PTNPalatin Technologies-$17.31MN/AN/AN/AN/AN/A-5,516.91%-114.82%5/19/2026 (Estimated)RENXSafe and Green Development-$15.96M-$89.80N/AN/AN/A-194.13%-577.52%-50.64%N/ALatest PTN, YGEN, MXCT, and RENX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q3 2026PTNPalatin Technologies-$1.2433N/AN/AN/A$1.28 millionN/A5/12/2026Q1 2026MXCTMaxCyte-$0.10N/AN/AN/A$7.28 millionN/A4/1/2026Q4 2025RENXSafe and Green DevelopmentN/A$3.01N/A$3.01N/A$5.57 million3/24/2026Q4 2025MXCTMaxCyte-$0.08-$0.06+$0.02-$0.09$9.16 million$6.76 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMXCTMaxCyteN/AN/AN/AN/AN/APTNPalatin TechnologiesN/AN/AN/AN/AN/ARENXSafe and Green DevelopmentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMXCTMaxCyteN/A8.307.77PTNPalatin TechnologiesN/A2.762.76RENXSafe and Green Development2.100.050.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMXCTMaxCyte68.81%PTNPalatin Technologies11.50%RENXSafe and Green Development2.59%Insider OwnershipCompanyInsider OwnershipMXCTMaxCyte3.30%PTNPalatin Technologies7.10%RENXSafe and Green Development61.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMXCTMaxCyte80107.12 million103.59 millionOptionablePTNPalatin Technologies301.77 million1.65 millionN/ARENXSafe and Green Development22.51 million973,000Not OptionablePTN, YGEN, MXCT, and RENX HeadlinesRecent News About These CompaniesRenX Enterprises Corp. Secures Initial $13 Million of PIPE Financing; Up to $87 Million in Additional Financing AvailableMay 5 at 9:00 AM | globenewswire.comSafe and Green Development (NASDAQ:RENX) Cut to "Sell" at Wall Street ZenMay 2, 2026 | americanbankingnews.comRenX Enterprises Expects First Quarter 2026 Revenue of More Than $3.5 MillionApril 22, 2026 | globenewswire.comUPDATE - The Vanderbilt Report Initiates Coverage of RenX Enterprises Corp. - 2025 Results Beat Guidance on Every Material MetricApril 14, 2026 | globenewswire.comRenX Enterprises Reports Record Full-Year Results as Microtec UTM 1200 Turbo Mill Ships from GermanyApril 14, 2026 | globenewswire.comRenX Enterprises Renews Major Organic Waste Transport Partnership Responsible For More Than $3 Million in Revenue in 2025April 6, 2026 | globenewswire.comRenX reports $8.2M revenue and $15.9M net loss in first year after recycling pivotApril 1, 2026 | msn.comRenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy DebtApril 1, 2026 | globenewswire.comRenX Enterprises Prices $6.0 Million Private Placement with Fixed Conversion PriceFebruary 13, 2026 | globenewswire.comRenX Enterprises Expands Contracted Inbound Volumes, Advancing Biomass Processing PlatformJanuary 30, 2026 | globenewswire.comSnowline Gold And First Nation of Na-Cho Nyäk Dun Sign Memorandum of UnderstandingJanuary 19, 2026 | accessnewswire.comARenX Enterprises Completes Debt Restructuring, Transfers Lago Vista Property to Lender for Conditional $5.0 Million Valuation Strengthening Balance Sheet and Advancing ...January 17, 2026 | theglobeandmail.comRenX Enterprises Corp. Appoints Bob Jacobson as Strategic Business Development Advisor for Engineered Soils and Potting MediaJanuary 14, 2026 | quiverquant.comQRenX Enterprises Corp. Highlights Transformational Year with Expected $7 Million in Revenues during 2025, Operating Scale, and Debt ReductionJanuary 9, 2026 | globenewswire.comRenX Enterprises Completes Purchase of Komptech Crambo Shredder and Diamond Z Horizontal Grinder Following Strong Operating PerformanceJanuary 7, 2026 | globenewswire.comSnowline Gold Reflects On A Transformational 2025 And Looks Ahead To 2026January 6, 2026 | accessnewswire.comARenX Enterprises Corp., Formerly Safe and Green Development Corporation, Announces Corporate Name Change; New Ticker Symbol “RENX”December 18, 2025 | finance.yahoo.comSafe and Green Development Corporation Obtains 25% Pricing Increase on Recurring Compost Purchase OrdersDecember 16, 2025 | globenewswire.comSafe and Green Development secures delivery of patented Micotec millDecember 9, 2025 | msn.comSafe and Green approves stock issuance proposalsDecember 9, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePTN, YGEN, MXCT, and RENX Company DescriptionsMaxCyte NASDAQ:MXCT$0.84 -0.03 (-3.24%) Closing price 04:00 PM EasternExtended Trading$0.84 0.00 (-0.27%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.Palatin Technologies NYSEAMERICAN:PTN$19.47 +0.57 (+3.02%) Closing price 04:10 PM EasternExtended Trading$19.50 +0.03 (+0.13%) As of 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.Safe and Green Development NASDAQ:RENX$2.03 -0.17 (-7.73%) As of 04:00 PM EasternSafe and Green Development Corporation operates as a real estate development company. It focuses on building single and multifamily projects. The company was formerly known as SGB Development Corp. and changed its name to Safe and Green Development Corporation in December 2022. The company was incorporated in 2021 and is based in Miami, Florida. Safe and Green Development Corporation is a subsidiary of Safe & Green Holdings Corp. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
